Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Melanoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Basal Cell 1

Interventions

HhAntag691 11 sonidegib 5 cemiplimab 5 methyl 5-aminolevulinate 4 daromun 4 Imiquimod 3 IPI-926 3 gusacitinib 2 Photochemotherapy 2 Drug Evaluation 2 3-ingenyl angelate 2 tozuleristide 1 silmitasertib 1 pembrolizumab 1 TAK-441 1 NVP-LEQ506 1 MAPRE1 protein, human 1 Intravital Microscopy 1 Interleukin-2 1 Injections 1 IFL protocol 1 Folfox protocol 1 Capecitabine 1 Bevacizumab 1 BO-112 1 BMS-833923 1 BF-200 ALA 1 Ascorbic Acid 1 Aminolevulinic Acid 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Carcinoma, Basal Cell × BO-112 × Clear all

NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡